{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:27:26Z","timestamp":1784431646473,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Non-alcoholic fatty liver diseases (NAFLDs) along with metabolic syndrome and Type-2 diabetes (T2D) are increasingly prevalent worldwide. Without an effective resolution, simple hepatic steatosis may lead to non-alcoholic steatohepatitis (NASH), characterized by hepatocyte damage, chronic inflammation, necrosis, fatty degeneration, and cirrhosis. The gut microbiome is vital for metabolic homeostasis. Conversely, dysbiosis contributes to metabolic diseases including NAFLD. Specifically, diet composition is critical for the enterotype of gut microbiota. We reasoned that green pigment rich in vegetables may modulate the gut microbiome for metabolic homeostasis. In this study, C57BL\/6 mice under a high fat diet (HFD) were treated with sodium copper chlorophyllin (CHL), a water-soluble derivative of chlorophyll, in drinking water. After 28 weeks of HFD feeding, liver steatosis was established accompanied by gut microbiota dysbiosis, intestinal impairment, endotoxemia, systemic inflammation, and insulin resistance. Administration of CHL effectively alleviated systemic and intestinal inflammation and maintained tight junction in the intestinal barrier. CHL rebalanced gut microbiota in the mice under high fat feeding and attenuated hepatic steatosis, insulin resistance, dyslipidemia, and reduced body weight. Fecal flora transplants from the CHL-treated mice ameliorated steatosis as well. Thus, dietary green pigment or the administration of CHL may maintain gut eubiosis and intestinal integrity to attenuate systemic inflammation and relieve NASH.<\/jats:p>","DOI":"10.3389\/fphys.2021.739174","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T06:15:23Z","timestamp":1635228923000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"You","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xile","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Chatelier","year":"2013","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/em.2850220309","article-title":"Antimutagenic potency of chlorophyllin in the Salmonella assay and its correlation with binding constants of mutagen-inhibitor complexes","volume":"22","author":"Dashwood","year":"1993","journal-title":"Environ. Mol. Mutagen."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.4049\/jimmunol.1800113","article-title":"CD71(+) Erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1","volume":"200","author":"Delyea","year":"2018","journal-title":"J. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.3748\/wjg.v21.i24.7427","article-title":"Liver fibrosis markers of nonalcoholic steatohepatitis","volume":"21","author":"Enomoto","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/carcin\/bgi068","article-title":"Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes","volume":"26","author":"Fahey","year":"2005","journal-title":"Carcinogenesis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jgh.12407","article-title":"Diet and exercise in management of obesity and overweight","volume":"28","author":"Fock","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","article-title":"Role of gut dysbiosis in liver diseases: what have we learned so far?","volume":"7","author":"Fukui","year":"2019","journal-title":"Diseases"},{"key":"B16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/MEG.0000000000000348","article-title":"Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease","volume":"27","author":"Gangarapu","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.00109.2020","article-title":"Adipose tissue macrophage burden, systemic inflammation, and insulin resistance","volume":"319","author":"Jia","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","article-title":"Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis","volume":"50","author":"Jiao","year":"2018","journal-title":"Physiol. Genomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/hep.23711","article-title":"Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease","volume":"52","author":"Johnson","year":"2010","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2018","journal-title":"Embo Mol. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.freeradbiomed.2009.06.008","article-title":"Structure activity relationship of carotenoid derivatives in activation of the electrophile\/antioxidant response element transcription system","volume":"47","author":"Linnewiel","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1572-0241.2001.03636.x","article-title":"Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function","volume":"96","author":"Madrid","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1096\/fj.10.164921","article-title":"Germ-free C57BL\/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism","volume":"24","author":"Rabot","year":"2010","journal-title":"Faseb J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Roy","year":"2013","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-1161(96)90016-3","article-title":"Chlorophyll and chromosome breakage","volume":"360","author":"Sarkar","year":"1996","journal-title":"Mutat. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol. Int."},{"key":"B36","first-page":"589","article-title":"Pilot study of topical copper chlorophyllin complex in subjects with facial acne and large pores","volume":"14","author":"Stephens","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models","volume":"7","author":"Su","year":"2016","journal-title":"Front. Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1524-475X.2007.00279.x","article-title":"Influence of papain urea copper chlorophyllin on wound matrix remodeling","volume":"15","author":"Telgenhoff","year":"2007","journal-title":"Wound Repair Regen."},{"key":"B39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.foodres.2011.10.031","article-title":"Copper chlorophyllin: a food colorant with bioactive properties?","volume":"46","author":"Tumolo","year":"2012","journal-title":"Food Res. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/19440049.2011.563370","article-title":"Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review","volume":"29","author":"Wogan","year":"2012","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo Risk Assess."},{"key":"B47","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","article-title":"Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis","volume":"94","author":"Yang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3945\/jn.112.172460","article-title":"Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL\/6 mice fed a high-fat diet","volume":"143","author":"Zeng","year":"2013","journal-title":"J. Nutr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3389\/fphys.2018.01671","article-title":"Chlorophyllin modulates gut microbiota and inhibits intestinal inflammation to ameliorate hepatic fibrosis in mice","volume":"9","author":"Zheng","year":"2018","journal-title":"Front. Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2337\/db17-0070","article-title":"Cationic polystyrene resolves nonalcoholic steatohepatitis, obesity, and metabolic disorders by promoting eubiosis of gut microbiota and decreasing endotoxemia","volume":"66","author":"Zhu","year":"2017","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH\u2020\u2021","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.739174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T06:15:27Z","timestamp":1635228927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.739174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":52,"alternative-id":["10.3389\/fphys.2021.739174"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.739174","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"article-number":"739174"}}